Tag: <span>Mesothelioma News</span>

Five Prime Therapeutics Announces Upcoming Presentations at the 2014…

Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that data related to FP-1039 , an FGF ligand trap in a global,…

Five Prime Therapeutics Announces Upcoming Presentations at the 2014…

Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that data related to FP-1039 , an FGF ligand trap in a global,…

New study suggests breast cancer drug may shrink mesothelioma tumors

After new evidence surfaced suggesting the enzyme aromatase is associated with malignant mesothelioma, Italian scientists began testing breast cancer drug Aromasin (exemestane) on mice and mesothelioma cells. Designed to inhibit aromatase, Aromasin curbs cell growth in breast cancer patients by helping reduce the amount of estrogen in the body. In the mesothelioma cells and mice, […]